A Case Report of Refractory Gout: Efficacy of High-Dose Anti-IL1r Treatment
Abstract
Gout is an inflammatory disease characterized by the deposition of monosodium urate (MSU) crystals in joints and other tissues. In a significant portion of patients, hyperuricemia is part of the metabolic syndrome; therefore, secondary causes of gout should be looked for and treated. The authors present a case of a persistent and refractory gout, despite standard therapeutics, leading to the need to explore a new pharmacological approach - anti-IL1r.
J Med Cases. 2017;8(4):124-126
doi: https://doi.org/10.14740/jmc2790w